Ownership

H. Westphal

Insider Reports History

Entity: Individual
Location: C/O Alnylam Pharmaceuticals, Inc, 300 Third Street, Cambridge, MA
Signature: /s/ Christoph Westphal
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by H. Westphal:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
TScan Therapeutics, Inc.	10%+ Owner	Voting Common Stock	1.28M	$6.35M	$4.97	Jul 20, 2021	Indirect
TScan Therapeutics, Inc.	10%+ Owner	Voting Common Stock	915K	$4.54M	$4.97	Jul 20, 2021	Direct
TScan Therapeutics, Inc.	10%+ Owner	Series A Preferred Stock	0			Jul 20, 2021	Indirect
TScan Therapeutics, Inc.	10%+ Owner	Series B Preferred Stock	0			Jul 20, 2021	Indirect
TScan Therapeutics, Inc.	10%+ Owner	Series C Preferred Stock	0			Jul 20, 2021	Indirect

Showing 1 to 5 of 5 entries

Insider Reports Filed by H. Westphal

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
TCRX	TScan Therapeutics, Inc.	Jul 20, 2021	5	$2M	4	Jul 22, 2021	10%+ Owner
TCRX	TScan Therapeutics, Inc.	Jul 15, 2021	0	$0	3	Jul 15, 2021	Director, 10%+ Owner